Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG
Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG Glycomine, Inc., a clinical-stage biotechnology company dedicated to developing life-changing therapies for patients suffering from orphan…
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer EveryONE Medicines, a trailblazing biotech company transforming the way individualized therapies are developed for children suffering from ultra-rare…
Aptar Launches Study to Speed FDA Approval of SmartTrack™ Platform for Inhalers
Aptar Launches Study to Speed FDA Approval of SmartTrack™ Platform for Inhalers AptarGroup, Inc., a global leader in drug delivery and consumer product dispensing systems, has announced a pivotal step…
Flatiron Health Partners with Veeva to Advance Oncology Research
Flatiron Health Partners with Veeva to Advance Oncology Research In a significant development for the digital health and clinical research sectors, Flatiron Health—a pioneer in healthtech focused on transforming clinical…
PursueCare to Highlight Digital Therapeutics at 2025 Rx Summit in Nashville
PursueCare to Highlight Digital Therapeutics at 2025 Rx Summit in Nashville PursueCare, a leader in virtual addiction treatment and medication-assisted therapy, is pleased to announce its participation in the 2025…
Octave Bioscience’s MSDA Test Demonstrates Clinically Actionable Insights for Improved MS Care Decisions
Octave Bioscience’s MSDA Test Demonstrates Clinically Actionable Insights for Improved MS Care Decisions In a significant advancement for the field of neurodegenerative disease management, Octave Bioscience, Inc., a precision care…
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59 Pfizer Inc. (NYSE: PFE) has taken a significant step forward in the effort to combat respiratory syncytial virus (RSV)…
GSK’s 5-in-1 Meningitis Vaccine PENMENVY Backed by U.S. Advisory Panel
GSK’s 5-in-1 Meningitis Vaccine PENMENVY Backed by U.S. Advisory Panel In a pivotal step forward for meningococcal disease prevention in the United States, GSK plc announced that the Advisory Committee…
eGenesis and OrganOx Secure U.S. FDA IND Clearance for Acute-On-Chronic Liver Failure Treatment
eGenesis and OrganOx Secure U.S. FDA IND Clearance for Acute-On-Chronic Liver Failure Treatment eGenesis, a pioneering biotechnology company focused on developing human-compatible engineered organs, and OrganOx Ltd., a leading medical…
ImmunityBio Files Supplemental BLA for NMIBC and Expands ANKTIVA Access for Lymphopenia Treatment
ImmunityBio Files Supplemental BLA for NMIBC and Expands ANKTIVA Access for Lymphopenia Treatment ImmunityBio, Inc. (NASDAQ: IBRX), a leading company specializing in immunotherapy, has recently made significant strides in advancing…
Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment
Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment Tivic Health Systems, Inc. , a diversified therapeutics company focused on advancing innovative treatment solutions, has made…
Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment
Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment In a groundbreaking move aimed at advancing precision medicine in the realm of autoimmune diseases, Scipher Medicine, a…